Further quantification of lung sections showed that there was an ~2.7-fold increase in the tumor number and an ~2.65-fold increase in tumor area in KrasG12D/+;Med23f/f;Spc-creERT2 mice compared with control mice (Fig. 1h). This evidence concerns the gene SFTPC and neoplasm.